Back to News
Market Impact: 0.2
Rani Therapeutics Announces Acceptance into U.S. FDA's Emerging Technology Program (ETP)
Source: GlobeNewswire
Healthcare & BiotechRegulation & LegislationTechnology & Innovation
The RaniPill® platform technology was accepted into the FDA's ETP, enabling early engagement with the agency to support its development. The item provides no financial figures, development milestones, or market reaction.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
More News
- Security researcher claims to they found KVM guest-host escape flaw
- SpaceX stock climbs to highest since June, returning Musk to trillionaire status
- Schneider Electric drops $22.6B on PTC as datacenter boom rains money on infra companies
- Security researcher claims they found KVM guest-host escape flaw
- Brazil Election: Bolsonaro Pushes Lula to Brink as Markets Set to Rally
- AstraZeneca CEO says Summit drug could drive next generation of cancer combinations after $2 billion investment